ATE392619T1 - Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen - Google Patents
Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungenInfo
- Publication number
- ATE392619T1 ATE392619T1 AT00948068T AT00948068T ATE392619T1 AT E392619 T1 ATE392619 T1 AT E392619T1 AT 00948068 T AT00948068 T AT 00948068T AT 00948068 T AT00948068 T AT 00948068T AT E392619 T1 ATE392619 T1 AT E392619T1
- Authority
- AT
- Austria
- Prior art keywords
- synovial
- diagnosing
- osteoarticular diseases
- osteoarticular
- diseases
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000029076 Synovial disease Diseases 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 230000008368 synovial tissue degradation Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9908502A FR2795823B1 (fr) | 1999-07-01 | 1999-07-01 | Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE392619T1 true ATE392619T1 (de) | 2008-05-15 |
Family
ID=9547607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00948068T ATE392619T1 (de) | 1999-07-01 | 2000-06-30 | Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7015048B2 (de) |
| EP (1) | EP1210604B1 (de) |
| JP (1) | JP2003503737A (de) |
| AT (1) | ATE392619T1 (de) |
| CA (1) | CA2377886A1 (de) |
| DE (1) | DE60038614T2 (de) |
| ES (1) | ES2304351T3 (de) |
| FR (1) | FR2795823B1 (de) |
| WO (1) | WO2001002864A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002218026A1 (en) | 2000-11-09 | 2002-05-21 | The Brigham And Women's Hospital, Inc. | Cardiovascular disease diagnostic and therapeutic targets |
| EP3072978B1 (de) | 2002-05-09 | 2018-07-11 | The Brigham and Women's Hospital, Inc. | 1l1rl-1 als ein marker kardiovaskulärer krankheiten |
| ES2351623T3 (es) | 2006-04-24 | 2011-02-08 | Critical Care Diagnostics, Inc. | Predicción de la mortalidad y detección de una enfermedad grave. |
| PT2021796E (pt) * | 2006-05-01 | 2012-04-19 | Critical Care Diagnostics Inc | Diagnóstico de doença cardiovascular |
| HUE025058T2 (en) * | 2006-05-02 | 2016-01-28 | Critical Care Diagnostics Inc | Differential diagnosis of pulmonary and cardiovascular disease |
| FR2908413B1 (fr) | 2006-11-15 | 2009-03-06 | Synarc Soc Par Actions Simplif | Marqueur specifique d'une degradation oxydative de tissus contenant du collagene de type iii,moyens et methodes,kits de diagnostic de suivi ou de pronostic des pathologies ciblees par ce marqueur. |
| DK2827152T3 (en) | 2008-04-18 | 2016-09-12 | Critical Care Diagnostics Inc | PREDICTION OF RISK OF MAJOR ADVERSE HEART EVENTS |
| WO2009153783A1 (en) * | 2008-06-16 | 2009-12-23 | Mor Research Applications Ltd. | Monitoring skin metabolism products for evaluating burn injury |
| CN104737170A (zh) | 2012-08-21 | 2015-06-24 | 重症监护诊断股份有限公司 | 多标记风险分层 |
| JP7195568B2 (ja) * | 2018-03-22 | 2022-12-26 | 学校法人上智学院 | 複合体 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| US4973666A (en) * | 1987-11-06 | 1990-11-27 | Washington Research Foundation | Peptide fragments containing HP and LP cross-links |
| US5702909A (en) * | 1987-11-06 | 1997-12-30 | Washington Research Foundation | Methods of detecting collagen type II degradation in vivo |
| US5283197A (en) * | 1988-06-25 | 1994-02-01 | The Rowett Research Institute | Method of monitoring collagen degradation |
| GB8815174D0 (en) * | 1988-06-25 | 1988-08-03 | Rowett Research Inst | Method of monitoring collagen degradation |
| US5314804A (en) * | 1992-03-24 | 1994-05-24 | Serim Research Corporation | Test for Helicobacter pylori |
| US5736344A (en) * | 1992-12-17 | 1998-04-07 | Metra Biosystems, Inc. | Serum pyridinium crosslinks assay |
| WO1995002188A1 (en) * | 1993-07-12 | 1995-01-19 | The Regents Of The University Of California | Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
-
1999
- 1999-07-01 FR FR9908502A patent/FR2795823B1/fr not_active Expired - Fee Related
-
2000
- 2000-06-30 ES ES00948068T patent/ES2304351T3/es not_active Expired - Lifetime
- 2000-06-30 EP EP00948068A patent/EP1210604B1/de not_active Expired - Lifetime
- 2000-06-30 WO PCT/FR2000/001878 patent/WO2001002864A1/fr active IP Right Grant
- 2000-06-30 JP JP2001508060A patent/JP2003503737A/ja active Pending
- 2000-06-30 AT AT00948068T patent/ATE392619T1/de not_active IP Right Cessation
- 2000-06-30 CA CA002377886A patent/CA2377886A1/fr not_active Abandoned
- 2000-06-30 DE DE60038614T patent/DE60038614T2/de not_active Expired - Fee Related
-
2002
- 2002-01-02 US US10/038,192 patent/US7015048B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20020172978A1 (en) | 2002-11-21 |
| FR2795823A1 (fr) | 2001-01-05 |
| US7015048B2 (en) | 2006-03-21 |
| EP1210604A1 (de) | 2002-06-05 |
| EP1210604B1 (de) | 2008-04-16 |
| DE60038614D1 (de) | 2008-05-29 |
| DE60038614T2 (de) | 2009-06-25 |
| WO2001002864A1 (fr) | 2001-01-11 |
| FR2795823B1 (fr) | 2001-11-23 |
| JP2003503737A (ja) | 2003-01-28 |
| CA2377886A1 (fr) | 2001-01-11 |
| ES2304351T3 (es) | 2008-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE400219T1 (de) | Verfahren zur quantifizierung von menschlicher wachsamkeit | |
| EP1099102A4 (de) | Spurendetektion von analyten mit hilfe artifizieller olfaktometrie | |
| AU2001247311A1 (en) | A system and method for obtaining, processing and evaluating patient information for diagnosing disease and selecting treatment | |
| EP1085418A3 (de) | Verfahren und System zur Prüfung des Verhaltens von Prozeduren | |
| DE59903915D1 (de) | Verfahren zur frühen diagnose von carcinomen | |
| WO2005027732A3 (en) | Method for bone structure prognosis and simulated bone remodeling | |
| DE60233485D1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
| DE60325617D1 (de) | Verfahren zur diagnose von bauchspeicheldrüsenkrebs | |
| NO20000862D0 (no) | Elektrokjemisk system for bestemmelse av blodkoaguleringstid | |
| DE59908478D1 (de) | Informations-, bedien- und/oder beobachtungssystem mit modellbasierter benutzeroberfläche und verfahren zum modellbasierten bedienen und/oder beobachten | |
| DE69510336D1 (de) | Verfahren zur diagnose von praeklampsie | |
| ATE392619T1 (de) | Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen | |
| DE60038535D1 (de) | Verfahren und vorrichtung, speicherverfahren und - vorrichtung für informationsbeschaffung und -verarbeitung | |
| DE69722231D1 (de) | Hochgesättigter,carboxylierter nitril-copolymer-kautschuk und verfahren zu dessen herstellung | |
| DE69725606D1 (de) | Methoden für die diagnose von allergischen atemwegsaspergillosen | |
| PT879296E (pt) | Marcadores de adn para o tamanho da ninhada no suino | |
| WO2001037779A3 (en) | A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer | |
| ATE422334T1 (de) | System und verfahren zur gewebeanalyse | |
| DE69934983D1 (de) | Verfahren, vorrichtung und bildgebungsmodus für tomographische bildgebung | |
| WO2004045376A3 (en) | Screening methods to identify treatments for autoimmune disease | |
| DE60014064D1 (de) | Einetenascin-c isoform als marker für neoplasmen | |
| ATE275268T1 (de) | Verfahren zur diagnose von sjögren-syndrom | |
| ATE543429T1 (de) | Verfahren zur bestimmung des sympathikus-tonus und messsystem dafür | |
| ATE388632T1 (de) | Verfahren zur überwachung von schweinen | |
| ATE424562T1 (de) | Diagnose von lysosomalen speicherungskrankheiten unter verwendung von saposinen und anderen markern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |